Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates; Participants include the Bill & Melinda Gates Foundation, Bristol-Myers Squibb, Rock Springs Capital, Invesco Asset Management

Press/Media

Period24 Dec 2018

Media coverage

1

Media coverage

  • TitleVedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates; Participants include the Bill & Melinda Gates Foundation, Bristol-Myers Squibb, Rock Springs Capital, Invesco Asset Management
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date24/12/18
    PersonsJeremiah Faith
View all 1
View less